A Case of Recurrent Severe Hypocalcemia with Prolonged Hospitalization and Readmissions After Single Dose of Denosumab in Metastatic Prostate Cancer Patient

Denosumab is a human monoclonal antibody used to prevent skeletal-related events in prostate cancer patients with bone metastasis. Hypocalcemia ranging from mild to severe requiring prolonged hospitalization have been reported with the use of denosumab in patients with known risk factors such as chr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kc, Ojbindra, Dahal, Punya Hari, Koirala, Manisha, Kothagundla, Chandra Sekhar, Al Zaghal, Enas, Fahed, Rabih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Greater Baltimore Medical Center 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195064/
https://www.ncbi.nlm.nih.gov/pubmed/35712685
http://dx.doi.org/10.55729/2000-9666.1043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195064/
https://www.ncbi.nlm.nih.gov/pubmed/35712685
http://dx.doi.org/10.55729/2000-9666.1043

Ejemplares similares